Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Riprazo

Withdrawn

Human

Details

EMA number	EMEA/H/C/000853
ATC code	C09XA02
Authorisation	22 August 2007
Withdrawn	24 January 2013
Revision	8

Therapeutic indication

Treatment of essential hypertension.

MeSH: Hypertension

Group: Agents acting on the renin-angiotensin system

Active substances

Marketing Authorisation Holder

Novartis Europharm Ltd

Timeline

Filter by authority:

Riprazo withdrawn

24 Jan 2013

withdrawnregulatory

Riprazo authorised

22 Aug 2007

authorisedregulatory

Riprazo | uMedical